|
Tocieta 25 mg tbl flm 28x25 mg (blis.OPA/Al/PVC-Al)
25 mg
|
Filmom obalená tableta |
B02BX05
|
Zentiva, k.s. |
—
|
|
Tocieta 25 mg tbl flm 84x1x25 mg (blis.OPA/Al/PVC-Al - jednotk.bal.)
25 mg
|
Filmom obalená tableta |
B02BX05
|
Zentiva, k.s. |
—
|
|
Tocieta 25 mg tbl flm 84x25 mg (blis.OPA/Al/PVC-Al)
25 mg
|
Filmom obalená tableta |
B02BX05
|
Zentiva, k.s. |
—
|
|
Tocieta 50 mg tbl flm 14x1x50 mg (blis.OPA/Al/PVC-Al - jednotk.bal.)
50 mg
|
Filmom obalená tableta |
B02BX05
|
Zentiva, k.s. |
—
|
|
Tocieta 50 mg tbl flm 14x50 mg (blis.OPA/Al/PVC-Al)
50 mg
|
Filmom obalená tableta |
B02BX05
|
Zentiva, k.s. |
—
|
|
Tocieta 50 mg tbl flm 28x1x50 mg (blis.OPA/Al/PVC-Al - jednotk.bal.)
50 mg
|
Filmom obalená tableta |
B02BX05
|
Zentiva, k.s. |
—
|
|
Tocieta 50 mg tbl flm 28x50 mg (blis.OPA/Al/PVC-Al)
50 mg
|
Filmom obalená tableta |
B02BX05
|
Zentiva, k.s. |
—
|
|
Tocieta 50 mg tbl flm 84x1x50 mg (blis.OPA/Al/PVC-Al - jednotk.bal.)
50 mg
|
Filmom obalená tableta |
B02BX05
|
Zentiva, k.s. |
—
|
|
Tocieta 50 mg tbl flm 84x50 mg (blis.OPA/Al/PVC-Al)
50 mg
|
Filmom obalená tableta |
B02BX05
|
Zentiva, k.s. |
—
|
|
Tranexamic acid Kabi 10 mg/ml sol inf 10x100 ml/1000 mg (fľ.PE (KabiPac))
10 mg/ml
|
Infúzny roztok |
B02AA02
|
Fresenius Kabi s.r.o. |
—
|
|
Tranexamic acid Kabi 10 mg/ml sol inf 10x50 ml/500 mg (fľ.PE (KabiPac))
10 mg/ml
|
Infúzny roztok |
B02AA02
|
Fresenius Kabi s.r.o. |
—
|
|
Tranexamic acid Kabi 10 mg/ml sol inf 20x100 ml/1000 mg (fľ.PE (KabiPac))
10 mg/ml
|
Infúzny roztok |
B02AA02
|
Fresenius Kabi s.r.o. |
—
|
|
Tranexamic acid Kabi 10 mg/ml sol inf 20x50 ml/500 mg (fľ.PE (KabiPac))
10 mg/ml
|
Infúzny roztok |
B02AA02
|
Fresenius Kabi s.r.o. |
—
|
|
Tranexamic acid Kabi 10 mg/ml sol inf 40x100 ml/1000 mg (fľ.PE (KabiPac))
10 mg/ml
|
Infúzny roztok |
B02AA02
|
Fresenius Kabi s.r.o. |
—
|
|
Tranexamic acid Kabi 10 mg/ml sol inf 40x50 ml/500 mg (fľ.PE (KabiPac))
10 mg/ml
|
Infúzny roztok |
B02AA02
|
Fresenius Kabi s.r.o. |
—
|
|
Tranexamic acid Kabi 10 mg/ml sol inf 50x100 ml/1000 mg (fľ.PE (KabiPac))
10 mg/ml
|
Infúzny roztok |
B02AA02
|
Fresenius Kabi s.r.o. |
—
|
|
Tranexamic acid Kabi 10 mg/ml sol inf 50x50 ml/500 mg (fľ.PE (KabiPac))
10 mg/ml
|
Infúzny roztok |
B02AA02
|
Fresenius Kabi s.r.o. |
—
|
|
Trenolk 100 mg/ml injekčný roztok sol inj 5x5 ml (amp.skl.)
100 mg/ 1 ml
|
Injekčný roztok |
B02AA02
|
MAKPHARM d.o.o. |
—
|
|
Trenolk 500 mg filmom obalené tablety tbl flm 15x500 mg (blis.Al/PVC/PVDC)
500 mg
|
Filmom obalená tableta |
B02AA02
|
MAKPHARM d.o.o. |
—
|
|
Trenolk 500 mg filmom obalené tablety tbl flm 20x500 mg (blis.Al/PVC/PVDC)
500 mg
|
Filmom obalená tableta |
B02AA02
|
MAKPHARM d.o.o. |
—
|
|
Trenolk 500 mg filmom obalené tablety tbl flm 30x500 mg (blis.Al/PVC/PVDC)
500 mg
|
Filmom obalená tableta |
B02AA02
|
MAKPHARM d.o.o. |
—
|
|
Trenolk 500 mg filmom obalené tablety tbl flm 60x500 mg (blis.Al/PVC/PVDC)
500 mg
|
Filmom obalená tableta |
B02AA02
|
MAKPHARM d.o.o. |
—
|
|
Wilate 1000 plv iol 1x1000 IU FVIII/1000 IU VWF +1x10 ml solv. (liek.skl.)
1000 IU FVIII/1000 IU VWF
|
Prášok a rozpúšťadlo na injekčný roztok |
B02BD06
|
Octapharma (IP) SPRL |
—
|
|
Wilate 500 plv iol 1x500 IU FVIII/500 IU VWF +1x5 ml solv. (liek.skl.)
500 IU FVIII/500 IU VWF
|
Prášok a rozpúšťadlo na injekčný roztok |
B02BD06
|
Octapharma (IP) SPRL |
—
|